Clinical Trial Update: Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of everolimus with anti-estrogen therapy in hormone-receptor-positive, HER-2 negative advanced breast cancer has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-02-17